$DYCQ
DT Cloud Acquisition Corp

2023 Q4 Form 10-K Financial Statement

#000149315224011740 Filed on March 28, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $82.01K $87.27K
YoY Change 7.3%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $82.01K $87.27K
YoY Change 7.3%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$82.01K -$87.27K
YoY Change 7.3%
Income Tax
% Of Pretax Income
Net Earnings -$82.01K -$87.27K
YoY Change 7.3%
Net Earnings / Revenue
Basic Earnings Per Share -$0.06
Diluted Earnings Per Share -$0.05 -$0.06
COMMON SHARES
Basic Shares Outstanding 1.500M shares
Diluted Shares Outstanding 1.500M shares

Balance Sheet

Concept 2023 Q4 2023 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $494.8K $494.8K
YoY Change
Cash & Equivalents $494.8K
Short-Term Investments
Other Short-Term Assets $8.450K $8.450K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $503.3K $503.3K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $85.00K $85.00K
YoY Change -10.53%
Total Long-Term Assets $85.00K $85.00K $95.00K
YoY Change -10.53%
TOTAL ASSETS
Total Short-Term Assets $503.3K $503.3K
Total Long-Term Assets $85.00K $85.00K $95.00K
Total Assets $588.3K $588.3K $95.00K
YoY Change 519.23% 519.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $24.25K $24.25K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $217.6K $217.6K
YoY Change 43.8%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $731.9K $731.9K $151.3K
YoY Change 383.63% 383.62%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $731.9K $731.9K $151.3K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $731.9K $731.9K $151.3K
YoY Change 383.63% 383.62%
SHAREHOLDERS EQUITY
Retained Earnings -$168.6K -$81.33K
YoY Change 107.31%
Common Stock $173.00 $173.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$143.6K -$143.6K -$56.33K
YoY Change
Total Liabilities & Shareholders Equity $588.3K $588.3K $95.00K
YoY Change 519.23% 519.22%

Cashflow Statement

Concept 2023 Q4 2023 2022 Q4
OPERATING ACTIVITIES
Net Income -$82.01K -$87.27K
YoY Change 7.3%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $4.820K $4.818K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 490.0K $490.0K
YoY Change
NET CHANGE
Cash From Operating Activities 4.820K $4.818K
Cash From Investing Activities
Cash From Financing Activities 490.0K $490.0K
Net Change In Cash 494.8K $494.8K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $4.820K $4.818K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001944212
CY2022Q4 us-gaap Cash
Cash
usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q4 us-gaap Cash
Cash
usd
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
CY2023 DTCA Offering Costs Paid By Related Party
OfferingCostsPaidByRelatedParty
usd
CY2023 DTCA Deferred Offering Costs Paid By Sponsor In Exchange From Ordinary Shares
DeferredOfferingCostsPaidBySponsorInExchangeFromOrdinaryShares
usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-41967
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
30 Orange Street
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
London
CY2023 dei Entity Address Country
EntityAddressCountry
GB
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
WC2H 7HF
CY2023 dei City Area Code
CityAreaCode
+44
CY2023 dei Local Phone Number
LocalPhoneNumber
7918725316
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1828500 shares
CY2023 dei Auditor Firm
AuditorFirmId
206
CY2023 dei Auditor Name
AuditorName
MaloneBailey, LLP
CY2023 dei Auditor Location
AuditorLocation
Houston, Texas
CY2023Q4 us-gaap Cash
Cash
69818 usd
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
425000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8446 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
503264 usd
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
85000 usd
CY2022Q4 us-gaap Deferred Costs
DeferredCosts
95000 usd
CY2023Q4 us-gaap Assets
Assets
588264 usd
CY2022Q4 us-gaap Assets
Assets
95000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24247 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
731861 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
151326 usd
CY2023Q4 us-gaap Liabilities
Liabilities
731861 usd
CY2022Q4 us-gaap Liabilities
Liabilities
151326 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1725000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1725000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1725000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1725000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
173 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
173 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24827 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24827 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-168597 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-81326 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-143597 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-56326 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
588264 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
95000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
87271 usd
us-gaap Operating Expenses
OperatingExpenses
81326 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-87271 usd
us-gaap Net Income Loss
NetIncomeLoss
-81326 usd
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1500000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
1500000 shares
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-56326 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-87271 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-143597 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
us-gaap Net Income Loss
NetIncomeLoss
-81326 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-56326 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-56326 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-87271 usd
us-gaap Net Income Loss
NetIncomeLoss
-81326 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
8446 usd
CY2023 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
76288 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
81326 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
24247 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4818 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
490000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
490000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
494818 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
494818 usd
CY2023Q4 us-gaap Cash
Cash
69818 usd
CY2023Q4 us-gaap Escrow Deposit
EscrowDeposit
425000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
494818 usd
DTCA Offering Costs Paid By Related Party
OfferingCostsPaidByRelatedParty
151326 usd
DTCA Deferred Offering Costs Paid By Sponsor In Exchange From Ordinary Shares
DeferredOfferingCostsPaidBySponsorInExchangeFromOrdinaryShares
25000 usd
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.05
CY2023Q4 DTCA Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
CY2023Q4 us-gaap Deposits
Deposits
180000 usd
CY2023 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
2160000 usd
CY2023Q4 DTCA Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.05
CY2023Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.05
CY2023Q4 DTCA Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
CY2023Q4 us-gaap Share Price
SharePrice
10.00
CY2023Q4 DTCA Working Capital Loans
WorkingCapitalLoans
0 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84E_eus-gaap--UseOfEstimates_z2jG77ZabImc" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_zetIbI4ZDNDl">Use of estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing these financial statements in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 DTCA Working Capital Loans
WorkingCapitalLoans
0 usd
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1725000 shares
CY2022Q3 DTCA Ordinary Share Subject To Forfeiture
OrdinaryShareSubjectToForfeiture
225000 shares
CY2022Q3 DTCA Percentage Of Issued And Outstanding Shares After Initial Public Offering Collectively Held By Initial Stockholders
PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders
0.20 pure
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1725000 shares
us-gaap Proceeds From Loans
ProceedsFromLoans
176326 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
25000 usd
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1725000 shares
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
490000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 usd
CY2023 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each holder of a right will receive one-seventh (1/7) ordinary share upon consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon exchange of the rights.

Files In Submission

Name View Source Status
0001493152-24-011740-index-headers.html Edgar Link pending
0001493152-24-011740-index.html Edgar Link pending
0001493152-24-011740.txt Edgar Link pending
0001493152-24-011740-xbrl.zip Edgar Link pending
dtca-20231231.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-5.htm Edgar Link pending
ex97-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
dtca-20231231_def.xml Edgar Link unprocessable
dtca-20231231_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dtca-20231231_pre.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dtca-20231231_cal.xml Edgar Link unprocessable